LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 8.76 | 27.76 | 918 | 401 | 2.2885 | 1.4794 | MN20160318_Q01 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 10.46 | 27.76 | 1 | 438 | 0.0023 | -0.5660 | MN20160318_Q01 | I12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 10.46 | 27.76 | 1134 | 438 | 2.5852 | 1.5388 | MN20160318_Q01 | I12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 10.46 | 27.76 | 15 | 438 | 0.0342 | -0.1432 | MN20160318_Q01 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 10.46 | 27.76 | 949 | 438 | 2.1635 | 1.4277 | MN20160318_Q01 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 12.17 | 27.76 | 1 | 489 | 0.0020 | -0.5520 | MN20160318_Q01 | I12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 12.17 | 27.76 | 1190 | 489 | 2.4332 | 1.4793 | MN20160318_Q01 | I12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 12.17 | 27.76 | 62 | 489 | 0.1268 | 0.2143 | MN20160318_Q01 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 12.17 | 27.76 | 1018 | 489 | 2.0815 | 1.3875 | MN20160318_Q01 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 13.87 | 27.76 | 2 | 604 | 0.0033 | -0.4466 | MN20160318_Q01 | I12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 13.87 | 27.76 | 1276 | 604 | 2.1101 | 1.3658 | MN20160318_Q01 | I12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 13.87 | 27.76 | 330 | 604 | 0.5457 | 0.7453 | MN20160318_Q01 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 13.87 | 27.76 | 1103 | 604 | 1.8240 | 1.2895 | MN20160318_Q01 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 15.58 | 27.76 | 4 | 685 | 0.0058 | -0.3421 | MN20160318_Q01 | I12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 15.58 | 27.76 | 1376 | 685 | 2.0071 | 1.3250 | MN20160318_Q01 | I12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 15.58 | 27.76 | 534 | 685 | 0.7789 | 0.8949 | MN20160318_Q01 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 15.58 | 27.76 | 1197 | 685 | 1.7460 | 1.2560 | MN20160318_Q01 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 17.28 | 27.76 | 7 | 838 | 0.0083 | -0.2443 | MN20160318_Q01 | I12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 17.28 | 27.76 | 1470 | 838 | 1.7527 | 1.2418 | MN20160318_Q01 | I12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 17.28 | 27.76 | 1022 | 838 | 1.2185 | 1.0820 | MN20160318_Q01 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 17.28 | 27.76 | 1333 | 838 | 1.5893 | 1.1976 | MN20160318_Q01 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 18.98 | 27.76 | 7 | 941 | 0.0074 | -0.2374 | MN20160318_Q01 | I12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 18.98 | 27.76 | 1601 | 941 | 1.7011 | 1.2203 | MN20160318_Q01 | I12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 18.98 | 27.76 | 1232 | 941 | 1.3090 | 1.1088 | MN20160318_Q01 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 18.98 | 27.76 | 1460 | 941 | 1.5513 | 1.1804 | MN20160318_Q01 | K07 |